Advanced Strategies for Diagnosing Hyperphosphatemia

NB: We do not resell your papers. Upon ordering, we do an original paper exclusively for you.

NB: All your data is kept safe from the public.

Table of Contents

Stakeholder Groups
Convincing Methods
Strategy to Gain Stakeholder Buy-in
References

Stakeholder Groups

The proposed change is the implementation of more effective hyperphosphatemia diagnosis methods. Since hyperphosphatemia does not have vivid symptoms, it is often underdiagnosed, which results in patients’ bone disorders and severe complications. Therefore, it is essential to initiate research on effective hyperphosphatemia diagnosis techniques to ensure patients’ quality of life with severe conditions. Stakeholder groups interested in the research include three main ones: organization administrators, peers, and patients. Firstly, organization administrators, such as the CEO, CNO, and supervisors, constitute a primary group of stakeholders since they are responsible for allocating resources, providing permission, and implementing the research results in the facility practice. Since the group of secondary stakeholders, peer professionals, including nurse practitioners and interdisciplinary team members, share the same responsibility of diagnosing and providing care for patients, they might be interested in advancing the hyperphosphatemia diagnosis techniques for the benefit of patients and the enhancement of their nursing practice quality (Kallio, Tevameri & Vähätalo, 2018). Finally, patients and families constitute a primary stakeholder group that will benefit from the change implementation.

Convincing Methods

To convince people that the proposed change is important, a nurse might address the facts and intertwine them with the meaningful benefits that the change will provide. Facts and statistics might help attract attention to the problem. Moreover, the appeal to practice change in the context of evidence-based nursing would help reach the audience of healthcare professionals. In general, it is important to deliver clear and comprehensible messages with regard to stakeholder opinion.

Strategy to Gain Stakeholder Buy-in

Stakeholder Interests

The organizational administrators’ group stakeholders include the CEO and CNO, who share the same interests related to the research topic. Overall, the unpredictability of outcomes and the limited resources serve as restricting factors for the primary stakeholders, namely the CEO and the CNO (Fixsen, Seers, Polley & Robins, 2020). Therefore, these stakeholders might be interested in enhancing hyperphosphatemia diagnosis methods because it might reduce costs for late-diagnosed hyperphosphatemia treatment. Within the group of peers, nurses are the essential stakeholders. Their interest is validated by the necessity of improving the working conditions and reducing workload, which might be achieved once an innovative and more effective diagnosing approach is implemented. Lastly, patients and their families are interested in high-quality care and early disease diagnoses that are cost-efficient and timely, which is why they will be interested in the implementation of new hyperphosphatemia diagnosis methods.

Data Inclusion

The data that would be presented to stakeholders would differ. The difference in stakeholder interests validates the difference in information presentation. Indeed, as Carello, Lanzarone, and Mattia (2018) identified, three stakeholders are commonly addressed in practice change: patients, service providers, and operators. Each of these stakeholders has their interests and goals; for example, “patients are interested in a good quality of care; service provider managers must guarantee the service while keeping the operating costs low; operators require good working conditions and fair workload assignments” (Carello et al., 2018, p. 29). Therefore, statistics on mortality and morbidity caused by underdiagnosis and data on monetary and reputational benefits would suffice for organizational administrators (Konadu et al., 2020). As for peers, sheets illustrating the increase in work efficiency and decrease in the workload due to innovative diagnosis solutions would be appropriate. Patients would be interested in longevity and quality of life benefits as the outcome of change implementation.

Variance in Information Presentation Based on the Audience

When communicating with organizational leadership, the monetary benefits of the reduced treatment for severely ill patients, if diagnosed early, would be emphasized. It would encourage the decision-makers to invest in the efficiency and long-term benefits of the proposed change. To engage peers in the process of change, one should emphasize procedural improvement and the reduction of workload if a new method is implemented. Finally, when communicating with patients and their families, the progress of healthcare in the early stages of renal disease and more accurate diagnoses results would be a significant encouragement for them to engage in the change.

Research Contribution to Nursing Practice

In modern-day interdisciplinary and leadership-dependent healthcare systems, the implementation of change in nursing practice requires much effort on the initiator’s side. Identifying and engaging the correct stakeholders who perform as main change drivers and decision-makers responsible for allocating resources is important. However, despite the difficulties of identifying stakeholder interests and pursuing them to participate, changes in health care are essential, especially when they are related to procedures or health issues of urgent nature. One such issue is hyperphosphatemia, a severe condition characterized by serum phosphorus imbalance caused by kidney disease, renal dysfunction, diabetes, and other requirements (Rastogi, Bhatt, Rossetti & Beto, 2021). Thus, the research on diagnosis methods would improve the overall quality of nursing care delivered to patients with hyperphosphatemia at the early stages of the disease.

Future Research Implications

Possible options for early hyperphosphatemia diagnosis should be researched in-depth. Given the complexity of the problem and the lack of symptoms, the early signs of hyperphosphatemia should be investigated in various patient groups. Moreover, once the options for diagnosis are identified, trials should be initiated to validate their applicability. Overall, future researchers might concentrate on using technology in laboratory procedures to enhance the effectiveness and accuracy of diagnosis.

Recommended Changes

Firstly, it is essential to research the world’s best practices in lab diagnoses of hyperphosphatemia. Secondly, innovative tools should be introduced to make the diagnosis more accurate. Thirdly, nurses’ training should be initiated once the best applicable method is identified. Fourthly, obligatory screening for serum phosphorus imbalance should be initiated for patients with early kidney disease and diabetes signs. Finally, patient education should be initiated to emphasize the importance of early hyperphosphatemia diagnosis for reducing complications.

References

Carello, G., Lanzarone, E., & Mattia, S. (2018). The trade-off between stakeholders’ goals in the home care nurse-to-patient assignment problem. Operations Research for Health Care, 16, 29-40.

Fixsen, A., Seers, H., Polley, M., & Robins, J. (2020). Applying critical systems thinking to social prescribing: A relational model of stakeholder “buy-in”. BMC Health Services Research, 20(1), 1-13.

Goulao, B., Bruhn, H., Campbell, M., Ramsay, C., & Gillies, K. (2021). Patient and public involvement in numerical aspects of trials (PoINT): Exploring patient and public partners’ experiences and identifying stakeholder priorities. Trials, 22(1), 1-12.

Kallio, T., Tevameri, T., & Vähätalo, M. (2018). Nurses’ organizational roles – Stakeholders’ expectations. Professions and Professionalism, 8(2), e1973-e1973. Web.

Konadu, R., Owusu‐Agyei, S., Lartey, T. A., Danso, A., Adomako, S., & Amankwah‐Amoah, J. (2020). CEOs’ reputation, quality management and environmental innovation: The roles of stakeholder pressure and resource commitment. Business Strategy and the Environment, 29(6), 2310-2323.

Rastogi, A., Bhatt, N., Rossetti, S., & Beto, J. (2021). Management of hyperphosphatemia in end-stage renal disease: A new paradigm.Journal of Renal Nutrition, 31(1), 21-34.

Click Here To Order Now!